Description

Spirovac L5 contains a specially prepared, inactivated and adjuvanted unique strain of Leptospira borgpetersenii serovar hardjo (Type hardjo-bovis) together with inactivated and adjuvanted cultures of L. pomona, L. grippotyphosa, L. canicola and L. icterohaemorrhagiae.

Approved Uses

Spirovac L5 is for vaccination of healthy cattle, including pregnant cows and heifers, over 4 weeks of age, as an aid in preventing disease caused by the above organisms. In addition, it is especially recommended to prevent establishment of L. hardjo in the kidney, and thus shedding in the urine, for at least 12 months. Spirovac L5 also prevents the establishment of L. hardjo in the genital tract and aids in preventing infection of the fetus.

Key Advantages
- Spirovac® L5 protects against leptospirosis caused by L. borgpetersenii serovar hardjo (Type: hardjo-bovis), an antigen not contained in most L5 vaccines.

- Spirovac L5 prevents hardjo-bovis shedding and transmission with no detectable bacteria in kidneys or reproductive tract.

- Spirovac L5 provides 12 month duration of immunity (DOI) against hardjo-bovis urinary shedding, which means less time and labor required, increasing peace of mind.

- Spirovac L5 helps prevent hardjo-bovis transmission in utero and leads to more live calves.

- Spirovac L5 is safe for use in pregnant cows, making it easy to implement whole-herd protection.

- Spirovac L5 stimulates a robust cell-mediated immune response.

Packaging

Spirovac L5 is available in 10 dose vials and 50 dose vials.